Kaplan Fox Encourages Smartsheet Inc. (NYSE: SMAR) Investors Seeking Recovery to Contact the Firm Before October 5, 2026

Kaplan Fox & Kilsheimer LLP announced a securities class action against Smartsheet (NYSE: SMAR) for alleged share repurchases during June 1, 2024–September 23, 2024 while Smartsheet purportedly received a formal acquisition offer from the Blackstone/Vista consortium at prices “significantly above” the market. The complaint alleges Smartsheet should have disclosed the acquisition offer or refrained from buying shares from investors unaware of the offer. While the filing is not an earnings/guidance event, it raises governance/liability risk and could pressure sentiment around SMAR.

Analysis

This is mostly a legal overhang, not a new operating fundamental. The only real market mechanism is a nuisance discount on any residual SMAR exposure and a reputational/process drag on BX as a sponsor that can modestly raise diligence costs in future take-private situations. The second-order effect is more important than the headline: boards and buyback programs at software names under strategic review may become more conservative about repurchases and disclosure timing, which slightly improves governance risk premia across the small-cap enterprise software cohort.

The catalyst path is slow: these cases typically matter for sentiment in days, but cash impact is months to years and usually capped unless there is internal-document evidence of a disclosure failure. For BX, any share-price reaction should fade unless this becomes part of a broader pattern of process challenges or antitrust scrutiny on sponsor-led deals. For SMAR, the only meaningful downside would be if the litigation intersects with deal economics, insurance coverage, or a reopening of transaction terms; otherwise this is mainly settlement noise.

Contrarian view: the market may be overpricing the legal headline because plaintiffs’ firms routinely file before discovery and the expected value is often tiny versus headline rhetoric. If the stock already reflects transaction certainty, the better trade is not to short SMAR on litigation alone but to watch for whether the case broadens into disclosure/board-process risk for other software take-privates. Falsifiers are simple: early dismissal, insurance-backed settlement with immaterial cash cost, or no follow-through in BX implied volatility or credit spreads over the next 1-3 months.

Key Decisions for Investors

• Do not initiate a standalone SMAR short here; wait for evidence of economic damages beyond settlement noise. If the stock is already fully valued to deal terms, the legal headline is likely dead money rather than a fresh catalyst.
• Maintain a small tactical underweight / hedge on BX only if sponsor litigation headlines begin to cluster across portfolio companies; otherwise the expected value is too small for a directional short. Reassess if BX CDS or options-implied volatility widens 5-10% over 1-3 weeks.
• Watch software M&A names and buyout proxies for governance discount drift: MDB, TWLO, DDOG, and XSW as sentiment barometers. If similar litigation language repeats, consider a relative-value short basket vs. long quality software with no sponsor process risk.
• Set an alert on any SEC or company disclosure that confirms the timing and content of the acquisition offer relative to repurchase activity. That is the only information that would convert this from nuisance litigation into a real process-risk trade.